Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACE Study of carbocisteine for prevention of COPD exacerbations
ChiCTR-TRC-08000131Phase 4Completed
- Sponsor
- Guangzhou Institute of Respiratory Health
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of carbocisteine in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Guangzhou Institute of Respiratory Health. Primary endpoint: Frequency of acute exacerbation. Started May 2005; status: completed.
02
Drugs
carbocisteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-08000131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000131.